Albumin/Hyaluronic Acid Nanoparticle‐Laden Contact Lenses for the Ocular Delivery of 5‐Fluorouracil
Source abstract
Abstract
ABSTRACT Nanoparticle‐laden contact lenses are a formidable strategy for ocular drug delivery. However, incorporating nanoparticles to achieve sustained drug release without affecting the contact lenses' properties remains a challenging task. In this work, daily and monthly replacement silicone‐hydrogel contact lenses laden with bovine serum albumin/hyaluronic acid (BSA/HA) nanoparticles are presented. These nanoparticle‐laden contact lenses enable the sustained release of 5‐fluorouracil (5‐FU) in mimetic physiological conditions. The nanoparticle‐laden contact lenses display properties similar to neat contact lenses, including refractive index, water content, UV/visible transmittance and chemical structure. Noteworthy attributes include the BSA/HA nanoparticles' low polydispersity, negative surface charge and a hydrodynamic size of ~210 nm, as well as the high nanoparticle loading efficiency (~ 30%) of the contact lenses. Thereby, the BSA/HA nanoparticles are a promising strategy for developing nanoparticle‐laden contact lenses for therapeutic applications, namely for sustained drug delivery.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Ocular Surface and Contact Lens · Advanced Drug Delivery Systems · Biomedical Research and Pathophysiology
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Physics Centre of Minho and Porto Universities (CF‐UM‐UP) University of Minho Braga Portugal
LaPMET Associate Laboratory University of Minho Braga Portugal
Funding
Fundação para a Ciência e a Tecnologia
References (52)
Show source-provided references
1. 10.1177/175883401875717510.1177/1758834018757175 ↗
2. 10.1007/s00280-019-03860-z10.1007/s00280-019-03860-z ↗
3. 10.1016/j.addr.2024.11532110.1016/j.addr.2024.115321 ↗
4. 10.3390/molecules2619590510.3390/molecules26195905 ↗
5. 10.1016/j.jconrel.2021.01.03310.1016/j.jconrel.2021.01.033 ↗
6. 10.1080/21691401.2017.137667510.1080/21691401.2017.1376675 ↗
7. Phyllanthus Amarus: Ethnomedicinal Uses, Phytochemistry and Pharmacology: A Review
8. 10.1167/iovs.03-095910.1167/iovs.03-0959 ↗
9. 10.4155/tde.14.7510.4155/tde.14.75 ↗
10. 10.3390/polym1307110210.3390/polym13071102 ↗
11. 10.3390/molecules2618557710.3390/molecules26185577 ↗
12. 10.3109/10717544.2016.113834210.3109/10717544.2016.1138342 ↗
13. 10.1080/09205063.2020.171217510.1080/09205063.2020.1712175 ↗
14. 10.2165/00137696-200604030-0000210.2165/00137696-200604030-00002 ↗
15. 10.2147/OPTO.S25708110.2147/OPTO.S257081 ↗
16. 10.1016/j.ijpharm.2021.12109010.1016/j.ijpharm.2021.121090 ↗
17. 10.1016/j.clae.2019.04.01110.1016/j.clae.2019.04.011 ↗
18. 10.1016/j.ijpharm.2017.03.08210.1016/j.ijpharm.2017.03.082 ↗
19. 10.1021/acsami.2c2286010.1021/acsami.2c22860 ↗
20. 10.1016/j.actbio.2019.01.00410.1016/j.actbio.2019.01.004 ↗
21. 10.3390/pharmaceutics802001410.3390/pharmaceutics8020014 ↗
22. 10.1208/s12249-008-9146-510.1208/s12249-008-9146-5 ↗
23. High‐Entropy Photothermal Materials
24. 10.18632/oncotarget.1536310.18632/oncotarget.15363 ↗
25. 10.3390/molecules2207103010.3390/molecules22071030 ↗
26. Nanomedicine Nanotechnology
27. 10.1111/aos.1515910.1111/aos.15159 ↗
28. 10.1038/nrc107410.1038/nrc1074 ↗
29. 10.1245/ASO.2004.07.00410.1245/ASO.2004.07.004 ↗
30. 10.1016/j.ophtha.2016.02.03410.1016/j.ophtha.2016.02.034 ↗
31. 10.1097/ICO.000000000000347010.1097/ICO.0000000000003470 ↗
32. 10.1016/j.jtos.2022.08.00210.1016/j.jtos.2022.08.002 ↗
33. 10.1016/j.jddst.2024.10627810.1016/j.jddst.2024.106278 ↗
34. 10.1111/j.1445-5994.1979.tb04317.x10.1111/j.1445-5994.1979.tb04317.x ↗
35. 10.1177/107815521988664010.1177/1078155219886640 ↗
36. 10.1167/iovs.08-301610.1167/iovs.08-3016 ↗
37. 10.3390/pharmaceutics1002005710.3390/pharmaceutics10020057 ↗
38. 10.1016/j.ejpb.2013.06.01410.1016/j.ejpb.2013.06.014 ↗
39. 10.1016/j.jlumin.2015.07.03010.1016/j.jlumin.2015.07.030 ↗
40. 10.3390/polym1205112810.3390/polym12051128 ↗
41. 10.1016/j.jtos.2014.07.00210.1016/j.jtos.2014.07.002 ↗
42. 10.1016/j.ijbiomac.2024.13367710.1016/j.ijbiomac.2024.133677 ↗
43. 10.1016/j.ijbiomac.2023.12838510.1016/j.ijbiomac.2023.128385 ↗
44. 10.1038/s41598-024-55900-110.1038/s41598-024-55900-1 ↗
45. 10.1186/s12645-022-00120-310.1186/s12645-022-00120-3 ↗
46. 10.1016/0168-3659(87)90035-610.1016/0168-3659(87)90035-6 ↗
47. Kinetic Modeling on Drug Release From Controlled Drug Delivery Systems
48. 10.1016/j.actbio.2020.08.02510.1016/j.actbio.2020.08.025 ↗
49. Biomimetic‐Engineered Silicone Hydrogel Contact lens Materials
50. 10.1016/j.optom.2019.10.00210.1016/j.optom.2019.10.002 ↗
51. 10.1016/j.ijbiomac.2016.05.03210.1016/j.ijbiomac.2016.05.032 ↗
52. 10.3390/gels807041210.3390/gels8070412 ↗